Status:
COMPLETED
Feasibility Trial of a Mindfulness Based Intervention in Youth With Type 1 Diabetes
Lead Sponsor:
Children's National Research Institute
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
type1diabetes
Eligibility:
All Genders
12-17 years
Phase:
NA
Brief Summary
Type 1 diabetes (T1D) is one of the most common chronic illnesses of childhood. The involved treatment regimen, including daily insulin administration/pump management, frequent blood glucose checks, a...
Eligibility Criteria
Inclusion
- age 12-17y
- T1D, with at least 1-year duration of illness
- negative affectivity, defined as clinically elevated scores (T-score \>55 indicating at least mild depression/anxiety symptoms on either the PROMIS short form-depression and/or anxiety scales)
- A1c \>7.5%
- English-speaking
Exclusion
- no cognitive or developmental delays which would interfere with their ability to participate in the study
- are able and willing to complete questionnaires and intervention via the internet
- do not have severe depression or active or recent (within the past two months) suicidal ideation
- have no other serious medical conditions (e.g., cystic fibrosis, cancer).
Key Trial Info
Start Date :
March 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT05268393
Start Date
March 31 2022
End Date
July 31 2023
Last Update
February 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's National Hospital
Washington D.C., District of Columbia, United States, 20010